| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |